Early research (Phase 1)Study completedNCT00630058What this trial is testingMP-424, Peginterferon Alfa 2b, and Ribavirin in Hepatitis CWho this might be right forHepatitis C Tanabe Pharma Corporation 20
Large-scale testing (Phase 3)Study completedNCT01492426What this trial is testingStudy Comparing Daclatasvir (BMS-790052) With Telaprevir Combined With Peginterferon Alfa-2a and Ribavirin in Patients With Chronic Hepatitis C Virus InfectionWho this might be right forHepatitis C Bristol-Myers Squibb 605
Early research (Phase 1)Study completedNCT01038167What this trial is testingExamine the Effects of Telaprevir on the Pharmacokinetics of Cyclosporine and Tacrolimus in Healthy AdultsWho this might be right forHepatitis C Vertex Pharmaceuticals Incorporated 20
Large-scale testing (Phase 3)Study completedNCT02006745What this trial is testingOpen Label Trial of PEG-IFN, RBV & TVR vs. PEG-IFN & RBV Alone in Tx of HCV-1 in HIV-1 Co-infected Patients (CHAT)Who this might be right forHIV St Stephens Aids Trust 20
Early research (Phase 1)Study completedNCT00903773What this trial is testingVX-950-TiDP24-C132: A Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics of Telaprevir.Who this might be right forHepatitis CKidney Diseases Tibotec BVBA 24
Post-approval studies (Phase 4)WithdrawnNCT01415141What this trial is testingPeginterferon and Ribavirin, With or Without Telaprevir, for Genotype 1 Hepatitis C and IL28B CC PolymorphismWho this might be right forHepatitis C University of Vermont
Not applicableStudy completedNCT00916474What this trial is testingVirology Follow up Study in Subjects Previously Treated With TelaprevirWho this might be right forHepatitis C Vertex Pharmaceuticals Incorporated 408
Testing effectiveness (Phase 2)Study completedNCT00983853What this trial is testingSafety and Efficacy of Telaprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Subjects Co-Infected With Hepatitis C Virus (HCV) and HIVWho this might be right forHepatitis CHIV Infections Vertex Pharmaceuticals Incorporated 62
Large-scale testing (Phase 3)Study completedNCT00703118What this trial is testingA Safety and Effectiveness Study of Telaprevir in Chronic, Genotype 1, Hepatitis C Patients That Failed Previous Standard TreatmentWho this might be right forHepatitis C, Chronic Tibotec BVBA 663
Not applicableStudy completedNCT02452814What this trial is testingLong Term Extension Study is Designed to Monitor Long-Term Efficacy and Safety of Miravirsen Sodium in Combination With Telaprevir and Ribavirin in Subjects With Chronic Hepatitis C Virus Genotype 1 InfectionWho this might be right forHCV Hoffmann-La Roche 8
Testing effectiveness (Phase 2)Study completedNCT00420784What this trial is testingTelaprevir (VX-950), Pegasys and Copegus in Hepatitis C (PROVE3)Who this might be right forHepatitis C Vertex Pharmaceuticals Incorporated 465
Early research (Phase 1)Study completedNCT01657552What this trial is testingEltrombopag/Boceprevir and Eltrombopag/Telaprevir Drug-Drug Interaction Study In Healthy Adult SubjectsWho this might be right forThrombocytopaenia GlaxoSmithKline 56
Large-scale testing (Phase 3)Study completedNCT01498068What this trial is testingOpen-Label, Bridging Study of Telaprevir in Treatment-Naïve and Treatment-Experienced Russian Patients With Genotype 1 Chronic Hepatitis CWho this might be right forGenotype 1 Chronic Hepatitis C Janssen-Cilag International NV 36
Large-scale testing (Phase 3)Ended earlyNCT01821963What this trial is testingTelaprevir Plus Standard of Care (SOC) in HCV Associated Hepatocellular Carcinoma (HCC)Who this might be right forInfection M.D. Anderson Cancer Center 1
Large-scale testing (Phase 3)Study completedNCT01854528What this trial is testingEvaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) for Treatment of Chronic Hepatitis C Infection in Treatment-experienced AdultsWho this might be right forChronic Hepatitis C Infection AbbVie 148
Testing effectiveness (Phase 2)Study completedNCT00262483What this trial is testingPhase 2 Study of VX-950, Pegasys and Copegus in Hepatitis CWho this might be right forHepatitis C Vertex Pharmaceuticals Incorporated 12
Early research (Phase 1)Study completedNCT01786382What this trial is testingA Drug Interaction Study of the Effects of PPI-668 on the Pharmacokinetics of Midazolam and OmeprazoleWho this might be right forPharmacokinetic Assessments in Healthy Volunteers Presidio Pharmaceuticals, Inc. 24
Testing effectiveness (Phase 2)Study completedNCT01994486What this trial is testingOpen-Label Safety Study of Telaprevir and Sofosbuvir in Chronic Hepatitis C Genotype 1Who this might be right forHepatitis C, Chronic University of Florida 20
Large-scale testing (Phase 3)Study completedNCT01598090What this trial is testingPhase 3 Efficacy and Safety Study of Peginterferon Lambda-1a and Ribavirin With TelaprevirWho this might be right forHepatitis C Virus Bristol-Myers Squibb 881
Early research (Phase 1)Study completedNCT01275599What this trial is testingDrug-Drug Interaction Study Between Telaprevir and BuprenorphineWho this might be right forHepatitis COpioid-Related Disorders Vertex Pharmaceuticals Incorporated 16